Correlation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correlation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease ; volume:15 ; number:1 ; day:19 ; month:5 ; year:2017 ; pages:1-9 ; date:12.2017
Journal of translational medicine ; 15, Heft 1 (19.5.2017), 1-9, 12.2017
- Urheber
-
Karlas, Thomas
- Beteiligte Personen und Organisationen
-
Weise, Lara
Kuhn, Stephanie
Krenzien, Felix
Mehdorn, Matthias
Petroff, David
Linder, Nicolas
Schaudinn, Alexander
Busse, Harald
Keim, Volker
Pratschke, Johann
Wiegand, Johannes
Splith, Katrin
Schmelzle, Moritz
SpringerLink (Online service)
- DOI
-
10.1186/s12967-017-1208-6
- URN
-
urn:nbn:de:1111-201706101818
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 05:31 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Karlas, Thomas
- Weise, Lara
- Kuhn, Stephanie
- Krenzien, Felix
- Mehdorn, Matthias
- Petroff, David
- Linder, Nicolas
- Schaudinn, Alexander
- Busse, Harald
- Keim, Volker
- Pratschke, Johann
- Wiegand, Johannes
- Splith, Katrin
- Schmelzle, Moritz
- SpringerLink (Online service)
Ähnliche Objekte (12)
Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Non-alcoholic steatohepatitis in pregnancy: a case report
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
The effects of endurance training intervention on circulating cell-free DNA in participants with histologically proven non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Non-alcoholic steatohepatitis in pregnancy: a case report
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
The effects of endurance training intervention on circulating cell-free DNA in participants with histologically proven non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Non-alcoholic steatohepatitis in pregnancy: a case report
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm